News

In this study, high alarm rates from ambulatory chemotherapy pumps that caused disruptions in dose deliveries were analyzed and a quality improvement program was initiated to address concerns over safe delivery of chemotherapy to patients.

Researchers examined the impact of the shift toward oral anti-cancer drugs and the consequent rise in costs within the Oncology Care Model. The abstract was presented at the 2023 ASCO Quality Care Symposium in Boston, Massachusetts.

A recent study by Bruno Scodari, MD, and colleagues characterized oncologists who travel to rural areas to provide more access to cancer care and examined the effectiveness of this outreach method in reducing travel burden on patients.

An abstract presented at the 2023 ASCO Quality Care Symposium evaluated the impact of a quality improvement initiative to increase patient access to care and improve the overall patient experience.

Eric Severson, MD, PhD, Labcorp Oncology, examines genomic testing’s role in comprehensive oncology pathways.

Ray Page, DO, PhD, discusses how personalized medicine and clinical pathways intersect in ways that help drive the best outcomes for patients, and Mary E. Cooley, PhD, RN, FAAN, and David F. Lobach, MD, PhD, MS, Elimu Informatics, provide an...

Max Gordon, MD, and colleagues evaluated the long-term effects in patients with chronic lymphocytic leukemia who reported hypertension or cardiovascular issues while receiving ibrutinib.

Stephen B. Edge, MD, Roswell Park Comprehensive Cancer Center, provides an overview of how clinical pathways are utilized at Roswell Park.